Tesaro Gets Approval For Zejula, Expect U.S. Launch Late April
March 28, 2017 at 10:26 AM EDT
TESARO Inc (NASDAQ: TSRO) announced the FDA approval of Zejula (niraparib) in recurrent ovarian cancer maintenance with a broad label. ...
Tesaro Gets Approval For Zejula, Expect U.S. Launch Late AprilMarch 28, 2017 at 10:26 AM EDT
TESARO Inc (NASDAQ: TSRO) announced the FDA approval of Zejula (niraparib) in recurrent ovarian cancer maintenance with a broad label. ...
Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|